nonprofit logo

The New Clinical Program Development Corporation

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 061565494 ✦ New haven, CT ✦ Designated as a 501(c)(3)

Overview

What is The New Clinical Program Development Corporation?

The New Clinical Program Development Corporation is a nonprofit organization situated in New Haven, Connecticut, with an address at 789 Howard Avenue, 06519. Their mission is to support the development of innovative clinical programs and services at Yale University School of Medicine and Yale New Haven Hospital, ultimately enhancing patient care. They aim to contribute to the renovation of the Neurosciences Bed Tower at Yale New Haven Hospital's Saint Raphael Campus.


Official website here: www.none

Is The New Clinical Program Development Corporation legitimate?

The New Clinical Program Development Corporation is a legitimate nonprofit organization registered as a 501(c)(3) entity. The New Clinical Program Development Corporation submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0

For more financial information, click here


Official website here: www.none

What is the mission statement of The New Clinical Program Development Corporation?

The New Clinical Program Development Corporation is dedicated to fostering the creation of new and groundbreaking clinical programs and services. Their ultimate goal is to enhance patient care at Yale University School of Medicine and Yale New Haven Hospital. Through their efforts, they aim to support the development of innovative healthcare solutions. Currently, they are focusing on the renovation of a neurosciences bed tower at Yale New Haven Hospital, which is expected to significantly improve patient care. Their mission aligns with the commitment to advance healthcare and provide exceptional treatment to patients.


Official website here: www.none

Who is the CEO of The New Clinical Program Development Corporation?

Keith Churchwell is the President & Director of The New Clinical Program Development Corporation.


Official website here: www.none

What is the revenue of The New Clinical Program Development Corporation?

The New Clinical Program Development Corporation's revenue in 2022 was $40,000,013.


Official website here: www.none

Who are the executives of The New Clinical Program Development Corporation and what are their salaries?

Here are 3 key members and their salaries:

    Keith Churchwell (President & Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Babar Khokhar (Chairman & Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Arnim Dontes (Secretary & Director)
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.none

    Where can I find the form 990 for The New Clinical Program Development Corporation?

    The The New Clinical Program Development Corporation’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.none

    Learn more at the official website: www.none

    Mission Statement of The New Clinical Program Development Corporation

    The New Clinical Program Development Corporation, also known as NCPD, is a dedicated organization that champions the development of new and innovative clinical programs and services to enhance patient care at Yale University School of Medicine and Yale New Haven Hospital. NCPD's mission is geared towards fostering the growth of advanced medical initiatives, ultimately improving the quality of care provided to patients.

    NCPD plays a pivotal role in supporting the creation of cutting-edge clinical programs that cater to the evolving needs of patients. By working closely with Yale University School of Medicine and Yale New Haven Hospital, the organization facilitates the implementation of these innovative projects, which may include the introduction of new treatments, technologies, or procedures. Through its efforts, NCPD enables healthcare professionals to deliver superior patient care and remain at the forefront of medical advancements.

    Moreover, NCPD has taken on a significant endeavor by providing support for the renovation of the Neurosciences Bed Tower construction around Yale New Haven Hospital. This project represents an investment in the future of healthcare, ensuring that the hospital remains a state-of-the-art medical facility capable of accommodating the latest advancements in patient care. As a result, the organization's commitment to innovation and advancement in healthcare serves to benefit not only current patients but also future generations.

    Impact

    This information is meant to be a general summary of The New Clinical Program Development Corporation. Please take the time to review official sources before making any decisions based upon the content provided here.




    Thursday, August 15, 2024

    The impact of The New Clinical Program Development Corporation is significant in advancing the development of new and innovative clinical programs and services at the Yale University School of Medicine and Yale New Haven Hospital. By providing support for the renovation of the Neurosciences Bed Tower construction around Yale New Haven Hospital Saint Raphael Campus, this organization plays a crucial role in enhancing the rendering of patient care in the medical field. Through their mission to foster the creation of cutting-edge clinical programs, they contribute to improving the quality and effectiveness of healthcare services in New Haven, CT.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $13
  • Program Service Revenue: $0
  • Gross Receipts: $40,000,013

    • Assets and Liabilities:
  • Total Assets: $5,076
  • Total Liabilities: $0
  • Net Assets: $5,076
  • Organization Details

    Founding Year

    1999

    Principal Officer

    Keith Churchwell

    Main Address

    789 HOWARD AVENUE, NEW HAVEN, CT, 06519

    Website

    www.none

    NTEE Category

    Code: E12 - Health

    If you are a representative of The New Clinical Program Development Corporation and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.